Most of our charitable spend contributes to world-class ovarian cancer research.
Some 46% contributes to our life-saving research at our Ovarian Cancer Action Research Centre and 22% to BriTROC - a study into why ovarian cancer keeps coming back.
We want to make ovarian cancer treatment more effective and reduce the number of women who die from the disease.
Our Ovarian Cancer Action Research Centre drives new and more targeted treatment from preclinical studies, to clinical trials and into gynaceological clinics across the UK.
What are we researching?
Current research projects at our Ovarian Cancer Action Research Centre include:
- Identifying how to stop the growth of ovarian cancer
- Investigating how to prevent and reverse resistance to platinum-based chemotherapy
- Developing epigenetic biomarkers and therapies for ovarian cancer
- Identifying how proteins function inside normal versus ovarian cancer cells
- Identifying how cancer tumour biology affects surgery success for women with advanced ovarian cancer
- Studying why ovarian cancer keeps coming back
Our research funding is underpinned by the fundamental idea that the future can and will change.